Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-01-24FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, a combination product of fexofenadine hydrochloride and pseudo…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Assess the Efficacy and Safety of Rhinocort Aqua [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating the efficacy and safety of Rhinocort Aqua (budesonide nasal spray) for aller…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine [Phase 4]
Phase 4 trial evaluating fexofenadine, desloratadine, and placebo for suppression of wheal and flare in allergic rhinitis has been completed…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen [Phase 4]
Phase 4 trial evaluating whether fexofenadine HCl 180 mg plus montelukast sodium 10 mg reduces wheal and flare responses to seasonal allerge…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine [Phase 4]
Phase 4 trial evaluating the pharmacokinetics and safety of fexofenadine in healthy adults who are slow metabolizers of desloratadine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis [Phase 4]
This Phase IV open-label trial evaluated the safety and tolerability of once-daily AVAMYS nasal spray (fluticasone furoate) 110 mcg in Vietn…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) [Phase 3]
Phase 3 trial of depigmented and polymerized Olea europaea allergen extract (GPIT) for allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [Phase 2]
Phase 2 trial evaluating depigmented and polymerized Phleum pratense allergen extract for allergic rhinitis, allergic conjunctivitis, and as…
-
FDA approval · 2010-12-13FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original application for generic promethazine hydrochloride, enabling the sale of a generic antihis…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients [NA]
A completed clinical trial evaluating the efficacy of sublingual immunotherapy in patients with polysensitized allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) [Phase 3]
Phase 3 study evaluating desloratadine for persistent allergic rhinitis (Study P04684) has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy [Phase 2]
Phase 2 dose-finding trial of CYT003-QbG10 for house dust mite–induced rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating the safety of ToleroMune Ragweed in ragweed-allergic individuals with rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the safety of ToleroMune for house dust mite allergy in subjec…
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis
The update covers a study evaluating montelukast's impact on nasal epithelial cell inflammatory responses in individuals with asthma and all…
-
FDA approval · 2010-10-25FDA Approved: DESLORATADINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for desloratadine, a non-sedating antihistamine used to treat allergic rhinitis and urtica…
-
FDA approval · 2010-10-01FDA Approved: HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approved the original application for Hydrocodone polistirex and chlorpheniramine polistirex extended-release, a fixed-dose combination …
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects [Phase 1]
Phase 1 study evaluating the safety and tolerability of single and multiple doses of VAK694 in healthy and atopic subjects, including indivi…
-
FDA approval · 2010-09-03FDA Approved: ZYRTEC ALLERGY — Original Application (Kenvue Brands LLC)
FDA approved ZYRTEC ALLERGY (cetirizine hydrochloride) from Kenvue Brands LLC under an Original Application.
-
FDA approval · 2010-08-31FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Allergy Sinus (chlorpheniramine maleate, ibuprofen, and pseudoephedrine HCl) from Haleon U…
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis [Phase 2]
Phase 2 clinical trial assessing PF-03654764 with or without fexofenadine (Allegra) for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units [Phase 2]
Phase 2 trial assessing standardization and biological activity of Chortoglyphus Arcuatus Allergenic Extract for allergic rhinitis and aller…
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
A clinical trial update aiming to determine the optimal concentration of Dermatophagoides pteronyssinus allergen extract for skin prick test…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone [Phase 3]
A Phase 3 clinical trial update reports on oxidative stress markers in the upper and lower airways of atopic children treated with nebulized…
-
FDA approval · 2010-07-23FDA Approved: ALLERGY RELIEF CHILDRENS — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for Allergy Relief Children's cetirizine hydrochloride from CVS Pharmacy, indicating an approved mod…